Piperidolate

Chemical compound
  • A03AA30 (WHO)
Identifiers
  • 1-Ethylpiperidin-3-yl diphenylacetate
CAS Number
  • 82-98-4 checkY
PubChem CID
  • 4839
DrugBank
  • DB13351 checkY
ChemSpider
  • 4673 ☒N
UNII
  • RJO31255V9
KEGG
  • D08382 checkY
ChEMBL
  • ChEMBL1474977 ☒N
CompTox Dashboard (EPA)
  • DTXSID7048164 Edit this at Wikidata
ECHA InfoCard100.001.318 Edit this at WikidataChemical and physical dataFormulaC21H25NO2Molar mass323.436 g·mol−13D model (JSmol)
  • Interactive image
  • CCN1CCCC(C1)OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3
InChI
  • InChI=1S/C21H25NO2/c1-2-22-15-9-14-19(16-22)24-21(23)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-20H,2,9,14-16H2,1H3 ☒N
  • Key:KTHVBAZBLKXIHZ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2][3] It was first approved in 1954 and is no longer marketed in the United States.[1]

References

  1. ^ a b "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
  2. ^ "Piperidolate". drugs.com.
  3. ^ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.


  • v
  • t
  • e
Drugs for
functional
bowel
disorders
Antimuscarinics
Tertiary
amino group
Quaternary
ammonium
compounds
Phosphodiesterase
inhibitors
Acting on
serotonin receptors
Other
Belladonna
and derivatives
(antimuscarinics)Propulsives
  • v
  • t
  • e
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Nicotinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e